| P50 | author | Hanna Wehr | Q9286046 |
| | Agnieszka Ługowska | Q59679732 |
| | Małgorzata Bednarska-Makaruk | Q73516361 |
| | Alla Graban | Q83215308 |
| | Anna Bochyńska | Q83215311 |
| | Danuta Ryglewicz | Q98087639 |
| | Ksenia Sławińska | Q125341438 |
| P2093 | author name string | Magdalena Gugała-Iwaniuk | |
| | Anna Wiśniewska | |
| | Wanda Łojkowska | |
| P2860 | cites work | Diagnosis and Classification of Diabetes Mellitus | Q22255454 |
| | The human chitotriosidase gene. Nature of inherited enzyme deficiency | Q24315794 |
| | Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging | Q24629027 |
| | Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease | Q24630213 |
| | Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research | Q26751362 |
| | Immunomodulatory Effects of Chitotriosidase Enzyme | Q26765769 |
| | Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment | Q26799893 |
| | Resistin protection against endogenous Aβ neuronal cytotoxicity from mitochondrial pathway | Q39142456 |
| | Paraoxonase 1 (PON1) reduces macrophage inflammatory responses | Q39167265 |
| | Inflammatory markers and the risk of Alzheimer disease: the Framingham Study | Q40208679 |
| | Obesity-induced inflammatory changes in adipose tissue. | Q40348859 |
| | The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia | Q40377934 |
| | Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes | Q40837878 |
| | Plasma leptin levels and free leptin index in women with Alzheimer's disease | Q40840255 |
| | Effects of lipid removal on the molecular size and kinetic properties of bovine plasma arylesterase | Q41981761 |
| | Serum leptin is not altered nor related to cognitive decline in Alzheimer's disease | Q43843783 |
| | Obesity-related leptin regulates Alzheimer's Abeta | Q45171528 |
| | Relationships between human serum resistin, inflammatory markers and insulin resistance | Q46619133 |
| | Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. | Q46769718 |
| | Circulating leptin levels and weight loss in Alzheimer's disease patients | Q47220287 |
| | Cognitive patterns in relation to biomarkers of cerebrovascular disease and vascular risk factors. | Q50722387 |
| | Ghrelin and leptin secretion in patients with moderate Alzheimer's disease. | Q50759152 |
| | Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer's disease. | Q51040272 |
| | Adipocytokines, fat distribution, and insulin resistance in elderly men and women. | Q51526925 |
| | Altered serum levels of adipokines and insulin in probable Alzheimer's disease. | Q53462386 |
| | Resistin is an inflammatory marker of atherosclerosis in humans. | Q53870894 |
| | Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease | Q57812922 |
| | Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI | Q68789670 |
| | [Resistin: a pathogenic factor or a biomarker of metabolic disorders and inflammation?] | Q84956450 |
| | Alzheimer disease, inflammation, and novel inflammatory marker: resistin | Q95531679 |
| | Macrophages, inflammation, and insulin resistance | Q29614351 |
| | Adipocytokines: mediators linking adipose tissue, inflammation and immunity | Q29619393 |
| | Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Q29619465 |
| | Mild cognitive impairment: an overview. | Q31143111 |
| | Adipocytokines and CD34 progenitor cells in Alzheimer's disease | Q33919734 |
| | Leptin: a novel therapeutic strategy for Alzheimer's disease | Q34015256 |
| | Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease | Q34133643 |
| | Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects | Q34269697 |
| | Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting | Q34329395 |
| | Diagnosis and classification of diabetes mellitus | Q34425060 |
| | Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. | Q34436367 |
| | Adiponectin is protective against oxidative stress induced cytotoxicity in amyloid-beta neurotoxicity | Q34540588 |
| | HDL and cognition in neurodegenerative disorders. | Q34614842 |
| | Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage | Q34706104 |
| | Adipokines as novel biomarkers and regulators of the metabolic syndrome | Q34786187 |
| | Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat | Q35006662 |
| | Human resistin: found in translation from mouse to man | Q35087560 |
| | Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans | Q35304374 |
| | Circulating biomarkers of cognitive decline and dementia | Q36247934 |
| | Leptin: a potential cognitive enhancer? | Q36295304 |
| | Role of resistin in inflammation and inflammation-related diseases | Q36426108 |
| | Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study | Q36439930 |
| | Role of chitotriosidase (chitinase 1) under normal and disease conditions | Q36630259 |
| | Leptin, mild cognitive impairment, and dementia among elderly women | Q36686873 |
| | Adipocyte-derived factors in age-related dementia and their contribution to vascular and Alzheimer pathology | Q36767745 |
| | Leptin reduces Alzheimer's disease-related tau phosphorylation in neuronal cells | Q36959116 |
| | Lipids and adipokines as risk factors for Alzheimer's disease. | Q37066912 |
| | Adiponectin as a new paradigm for approaching Alzheimer's disease. | Q37420289 |
| | Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases | Q37527282 |
| | Serum leptin level and cognition in the elderly: Findings from the Health ABC Study | Q37612838 |
| | Peripheral cytokines and chemokines in Alzheimer's disease | Q37614788 |
| | Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease | Q37742828 |
| | From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century | Q38286539 |
| | Serum high-molecular-weight adiponectin level and incident dementia in patients with vascular risk factors | Q38930559 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P304 | page(s) | 561-580 | |
| P577 | publication date | 2017-04-18 | |
| P1433 | published in | Biogerontology | Q15765259 |
| P1476 | title | Association of adiponectin, leptin and resistin with inflammatory markers and obesity in dementia | |
| P478 | volume | 18 | |